Practice Management
The Centers for Disease Control and Prevention’s vaccine advisory committee voted on recommendations for 3 vaccines in recent days, according to CIDRAP. The committee recommended the use of the newly approved 5-in-1 meningococcal (groups A, B, C, W, and Y) vaccine as part of the adolescent meningococcal vaccination schedule. They also recommended that adults aged 50 to 59 years who are at increased risk of severe disease from respiratory syncytial virus (RSV) receive a single …
Read More
The Food and Drug Administration has approved a meningococcal ABCWY vaccine for use in individuals aged 10 to 25 years, according to a press release from manufacturer GSK. The vaccine targets 5 groups of the bacteria Neisseria meningitidis (A,B,C,W, and Y), which represent the most invasive meningococcal disease cases globally. The vaccine combines antigenic components of the meningococcal group B vaccine and meningococcal groups A, C, Y, and W-135 oligosaccharide diphtheria CRM197 conjugate vaccine. Trial …
Read More